Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-05-01
2007-05-01
Page, Thurman K. (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
10237306
ABSTRACT:
Disclosed are methods of treating acute and chronic inflammation in the lung caused by inhalation of smoke, endometriosis, Behcet's disease, uveitis, ankylosing spondylitis, pancreatitis, cancer, Lyme disease, sepsis, chronic obstructive pulmonary disease, traumatic arthritis, congestive heart failure and restenosis following percutaneous transluminal coronary angioplasty, known to be cytokine mediated, using aromatic heterocyclic compounds described in WO 00/55139.
REFERENCES:
patent: 6319921 (2001-11-01), Cirillo et al.
patent: 6358945 (2002-03-01), Breitfelder et al.
patent: 6608052 (2003-08-01), Breitfelder et al.
patent: 6720321 (2004-04-01), Cirillo et al.
patent: WO 99/23091 (1999-05-01), None
patent: WO 00/41698 (2000-07-01), None
patent: WO 00/55139 (2000-09-01), None
Moss Neil
Regan John Robinson
Boehringer Ingelheim Pharmaceuticals Inc.
Bottino Anthony P.
Devlin Mary-Ellen M.
Katakam Sudhakar
Morris Michael
LandOfFree
Methods of treating cytokine mediated diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating cytokine mediated diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating cytokine mediated diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3811900